# High Doses of Candesartan Cilexetil on the Reduction of Proteinuria

> **NCT00242346** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 270 (—)

## Conditions studied

- Proteinuria

## Interventions

- **DRUG:** candesartan cilexetil

## Key facts

- **NCT ID:** NCT00242346
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 270 (—)
- **Last updated:** 2007-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242346, "High Doses of Candesartan Cilexetil on the Reduction of Proteinuria". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00242346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*